Tel: +86-18971916286
Email: Andy@sanxinbio.com
产品中心
Home > Products > Liposomal Calcium Salt > Liposomal Calcium Lactate Gluconate 80% High Bioavailability Bone Health and Muscle Function Supplement

Liposomal Calcium Lactate Gluconate 80% High Bioavailability Bone Health and Muscle Function Supplement

    Liposomal Calcium Lactate Gluconate 80% High Bioavailability Bone Health and Muscle Function Supplement

    Specifications:
    • 80%:

      69$/KG

    CAS NO.: 11116-97-5
    Application: Bone health, osteoporosis prevention, bone mineral density support, muscle function, nerve transmission, cardiovascular support, pregnancy and lactation support
    Purity: ≥ 80% calcium lactate gluconate
    Appearance: White to off-white crystalline or granular powder
    Lead Time: In stock: 3–5 business days; Bulk/custom orders: 2–3 weeks
    Recommended Dosage: 500–1,200 mg elemental calcium per day
  • Share:
  • Contact us Inquiry
  • WhatsApp:sinoandy99

Product Detailed Description

Liposomal calcium lactate Gluconate 80% — High Bioavailability Bone Health Supplement

Product Overview

Liposomal calcium lactate gluconate 80% is a premium-grade dietary supplement ingredient delivering calcium lactate gluconate in an advanced liposomal delivery system. Calcium lactate gluconate (CAS 11116-97-5) is a water-soluble calcium complex formed from two molecules of calcium gluconate and three molecules of calcium lactate, chemically characterized by the molecular formula Ca₃(C₃H₅O₃)₆(C₆H₁₁O₇)₄·2H₂O and a molecular weight of 1551.4. Approximately 7.74 grams of calcium lactate gluconate (dihydrate) yields the equivalent of one gram of elemental calcium.

Calcium is the most abundant mineral in the human body, with approximately 99% stored in bones and teeth as hydroxyapatite complexes. The remaining 1% of "non-bone calcium" plays critical roles in muscle contraction, nerve impulse transmission, blood clotting, and hormone secretion. Calcium lactate gluconate is recognized as one of the most intensively researched organic calcium salts with regard to bioavailability, demonstrating superior effects on fractional absorption rate of calcium and bone mineral density.

Why Liposomal Technology?

Calcium lactate gluconate already offers superior bioavailability compared to calcium carbonate, with its high water solubility attributed to the presence of lactate and gluconate anions. However, even highly soluble calcium salts face absorption challenges related to saturable intestinal transport systems and interactions with dietary inhibitors.

Liposomal encapsulation provides four critical advantages:

1. Enhanced Bioavailability and Absorption — A randomized crossover human absorption study evaluated solid-state liposomal calcium versus non-liposomal calcium over an 8-hour period. Solid-state liposomal calcium significantly increased blood calcium levels at early time points (1–2 h; p < 0.05) and maintained elevated levels up to 8 hours post-administration. The AUC was 2.94 mg·h/dL for the liposomal group versus 1.88 mg·h/dL for the non-liposomal group, representing a 1.56-fold increase in systemic calcium exposure.

2. Protection from Dietary Inhibitors — The phospholipid bilayer shields calcium from binding with oxalates or phytates in the diet, which normally block absorption. liposomes protect active ingredients from being destroyed by gastric acid and digestive enzymes.

3. Enhanced Cellular Uptake — Liposomes fuse directly with intestinal cell membranes, facilitating efficient cellular delivery via lipid-mediated pathways. Due to their affinity with cell membranes, active substances can penetrate the intestinal wall more efficiently and enter the bloodstream and cells directly.

4. Gentle on the Gastrointestinal Tract — Liposomal encapsulation minimizes direct contact between calcium and the gastrointestinal mucosa, reducing the risk of bloating and constipation associated with traditional calcium salts.

Product Specifications

FieldDetails
Product NameLiposomal Calcium Lactate Gluconate 80%
CAS No.11116-97-5 (mixed salt); 814-80-2 (calcium lactate component); 18016-24-5 (calcium gluconate component)
Active IngredientCalcium Lactate Gluconate
Assay MethodComplexometric titration with 0.05 M disodium EDTA for calcium determination (USP method); reversed-phase HPLC with C18 column and 0.025 M NaH₂PO₄ mobile phase (pH 2.50) at 210 nm for simultaneous quantification of lactate and gluconate components; ICP-MS for heavy metal analysis
Purity≥ 80% calcium lactate gluconate; elemental calcium 12.92% (anhydrous basis); assay 96.0%–102.0% (TGA specification)
Appearance / ColorWhite to off-white crystalline or granular powder
OdorOdorless
Dosage FormLiposomal powder, water-dispersible
Recommended Dosage500–1,200 mg elemental calcium per day; clinical trials have used 500–1,250 mg/day calcium as calcium lactate gluconate for bone health
ApplicationBone health, osteoporosis prevention, bone mineral density support, muscle function, nerve transmission, cardiovascular support, pregnancy and lactation support
Extract SourceSynthetic (calcium lactate and calcium gluconate combined in aqueous solution followed by crystallization); sunflower phospholipid liposomal carrier system
Molecular FormulaCa₃(C₃H₅O₃)₆(C₆H₁₁O₇)₄·2H₂O
Molecular Weight1551.4 g/mol
Lead TimeIn stock: 3–5 business days; Bulk/custom orders: 2–3 weeks
Shipping MethodInternational Express (FedEx / DHL / UPS); air and sea freight available; worldwide shipping including remote areas
StorageStore in a cool, dry place away from direct sunlight and moisture; keep container tightly sealed. Shelf life: 24 months
Packaging1 kg/aluminum foil bag with two plastic bags inside; 25 kg/carton or fiber drum with aluminum foil bag inside

Key Features

  • High Purity — Standardized to ≥80% calcium lactate gluconate, with elemental calcium content of 12.92% and assay of 96.0%–102.0% (TGA specification).

  • Liposomal Enhancement — Phospholipid bilayer encapsulation achieves a 1.56-fold increase in systemic calcium exposure compared to non-liposomal calcium in human absorption study.

  • Superior Bioavailability — Calcium lactate gluconate is among the most intensively researched organic calcium salts with regard to bioavailability, demonstrating a superior effect on fractional absorption rate of calcium.

  • Clinically Validated for Bone Density — A meta-analysis of 16 clinical studies in elderly and late postmenopausal women demonstrated that calcium lactate gluconate supplementation increased BMD of the lumbar spine between +0.2 to +1.8%, whereas other supplements partly decreased BMD.

  • GRAS and FDA Affirmed — Calcium lactate gluconate has GRAS (Generally Recognized As Safe) status under FDA with a low order of toxicity.

  • Gentle on the Stomach — Liposomal encapsulation minimizes direct contact between calcium and the gastrointestinal mucosa, and calcium lactate gluconate is highly water-soluble and well-absorbed.

  • Water-Dispersible — High water solubility attributed to the presence of lactate and gluconate anions; suitable for capsules, tablets, powder drink mixes, and functional beverages.

  • Batch Traceability — Complete COA, HPLC chromatogram, and identity data provided for each batch.

Application & Formulation Guidance

ApplicationRecommended UsageNotes
Capsules / Tablets250–500 mg elemental calcium per serving2–3 capsules daily, with or without food
Functional Beverages100–250 mg per 250 mLWater-soluble; suitable for RTD formats
Powdered Drink Mixes500–1,000 mg per sachetBlend with vitamin D3 and K2 for synergistic bone support
Bone Health Formulas500–1,200 mg per servingClinical trials used 500–1,250 mg/day for BMD support
Pregnancy & Lactation Formulas500–1,000 mg per servingGentle, high-absorption calcium source for maternal nutrition

Recommended Dosage

According to the International Osteoporosis Foundation, the recommended daily calcium intake for both women and men aged 19 to 50 years is 1,000 mg, increasing to 1,200 mg from age 51 in women and after 70 in men. Clinical trials using calcium lactate gluconate for bone health have used 500–1,250 mg/day of calcium for 12–48 months. A meta-analysis of 16 clinical studies in elderly and late postmenopausal women compared supplementation with 500–1,250 mg/day calcium as calcium lactate gluconate, calcium carbonate, calcium citrate, and other salts for 12–48 months. The Tolerable Upper Intake Level (UL) for calcium is 2,000–2,500 mg per day for adults. Liposomal formulations may allow for more efficient utilization of lower doses due to enhanced bioavailability.

Shipping & Lead Time

  • Stock Orders: 3–5 business days after payment confirmation.

  • Bulk / Custom Orders: 2–3 weeks, depending on quantity and customization requirements.

  • Shipping Methods: International Express (FedEx, DHL, UPS), air freight, and sea freight.

  • Coverage: Worldwide shipping, including remote areas.

Calcium Lactate Gluconate Encyclopedia — Scientific Background

What Is Calcium Lactate Gluconate?

Calcium lactate gluconate (CAS 11116-97-5), also known as calcium gluconolactate or calcium lactate gluconate mixture, is a water-soluble calcium complex formed from two molecules of calcium gluconate and three molecules of calcium lactate. It is chemically characterized by the molecular formula Ca₃(C₃H₅O₃)₆(C₆H₁₁O₇)₄·2H₂O and a molecular weight of 1551.4 (Martindale: The Extra Pharmacopoeia 31st edition). Approximately 7.74 grams of calcium lactate gluconate (dihydrate) yields the equivalent of one gram of elemental calcium. The compound occurs as a white to off-white crystalline or granular powder that is odorless, has a neutral taste, and is highly soluble in water.

PropertyValue
CAS No.11116-97-5
EINECS234-379-5
Molecular FormulaCa₃(C₃H₅O₃)₆(C₆H₁₁O₇)₄·2H₂O
Molecular Weight1551.4 g/mol
AppearanceWhite to off-white crystalline or granular powder
OdorOdorless
SolubilityHighly soluble in water
Elemental Calcium12.92% (anhydrous basis)
pH (10% solution)6.0–8.0
Assay96.0%–102.0% (anhydrous basis)

Regulatory Status and Pharmacopoeial Standards

Calcium lactate gluconate holds a well-established regulatory position:

FDA GRAS Status — Calcium lactate gluconate has GRAS (Generally Recognized As Safe) status under FDA with a low order of toxicity. The FDA Substances Added to Food database lists calcium lactate gluconate with CAS Registry No. 11116-97-5.

TGA Compositional Guideline — The Australian Therapeutic Goods Administration (TGA) has established a draft compositional guideline for calcium lactate gluconate, specifying appearance as a white or yellow-tinged white crystalline or granular powder, assay of 96.0%–102.0% (anhydrous basis), loss on drying of 6% maximum, pH of 6.0–8.0 in a 10% solution, and heavy metal limits including arsenic <3.0 ppm and heavy metals <20 ppm.

Global Standards — Calcium lactate gluconate conforms to the Martindale: The Extra Pharmacopoeia 31st edition specifications and is widely used in pharmaceutical and food applications globally.

The Lactate-Gluconate Synergy

The unique combination of lactate and gluconate anions in a single calcium complex provides synergistic benefits. The high water solubility of calcium lactate gluconate is attributed to the presence of lactate and gluconate anions, which maintain calcium in a soluble form across a wide pH range. This solubility advantage ensures that calcium remains available for absorption even in the neutral pH environment of the small intestine, unlike calcium carbonate which requires gastric acid for dissolution.

Physiological Functions of Calcium

Calcium is the most abundant mineral in the human body, with approximately 99% stored in bones and teeth as hydroxyapatite complexes. Key physiological roles include:

  • Bone Structure — Calcium provides strength and structure to bones and teeth

  • Muscle Contraction — Calcium triggers the interaction between actin and myosin filaments necessary for muscle movement

  • Nerve Transmission — Calcium ions are essential for neurotransmitter release at synaptic junctions

  • Blood Clotting — Calcium is a cofactor for multiple clotting factors in the coagulation cascade

  • Cardiovascular Function — Calcium regulates heart rhythm and vascular tone

  • Hormone Secretion — Calcium signaling is required for the release of various hormones

Mechanisms of Action and Absorption

Conventional Calcium Absorption Pathway

Intestinal calcium absorption occurs through two distinct mechanisms:

Transcellular Absorption — An active, energy-dependent process that takes place primarily in the duodenum. It is dependent on the concentration of calcium-binding proteins and is rapidly saturable. This pathway requires active vitamin D.

Paracellular Absorption — A passive, energy-independent process that occurs throughout the intestine. It is independent of calcium concentration in the gut lumen and is not rapidly saturable. This pathway is not vitamin D dependent.

Calcium lactate gluconate is absorbed via the paracellular pathway, which does not require stomach acid for dissolution. This is why calcium lactate gluconate is absorbed equally well with or without food and is the preferred form for individuals with hypochlorhydria or those taking acid-reducing medications.

Bone Mineral Density Effects

Calcium lactate gluconate is among the most intensively researched organic calcium salts with regard to bioavailability. Its superior effect on fractional absorption rate of calcium, calcium bioavailability biomarkers (urinary and serum ionised calcium and PTH), and bone mineral density (BMD) have been extensively reviewed. In a study of 19 non-menopausal women with osteoporosis during or after hormone therapy, calcium lactate gluconate significantly reduced bone fracture rate. In a separate study of 50 Chinese women aged 62–92 years, calcium lactate gluconate increased BMD of the hip more than exercise.

liposomal Calcium Absorption

Liposomal encapsulation provides a fundamentally different absorption mechanism. The liposomal phospholipid bilayer is similar to cell membranes in the human body, which makes them progressively biocompatible. liposomes protect calcium from premature interaction with gastric contents and dietary inhibitors, and facilitate efficient cellular delivery via lipid-mediated pathways. In a randomized crossover human absorption study, solid-state liposomal calcium achieved a 1.56-fold increase in systemic calcium exposure compared to non-liposomal calcium.

Liposomal calcium lactate Gluconate

Liposomal encapsulation of calcium lactate gluconate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the calcium-lactate-gluconate complex, forming a protective shell that enhances absorption and enables targeted delivery. This delivery system:

  • Protects calcium from gastric acid degradation and dietary inhibitors

  • Enhances intestinal absorption through lipid-mediated pathways

  • Provides sustained release with prolonged calcium elevation

  • Minimizes direct contact between calcium and the gastrointestinal mucosa

Clinical Evidence

Bone Mineral Density — Meta-Analysis

A meta-analysis by Schaafsma et al. (2001) compared 16 clinical studies in elderly and late postmenopausal women (mean age 58–79 years) who were supplemented for 12–48 months with 500–1,250 mg/day calcium as calcium lactate gluconate, calcium carbonate, calcium citrate, and other salts. Without exception, intake of calcium lactate gluconate increased BMD of the lumbar spine between +0.2 to +1.8%, whereas other supplements, even very well absorbable salts such as calcium citrate malate, partly decreased BMD. This suggests that supplementation with calcium lactate gluconate is likely to improve bone health more effectively than calcium citrate malate or calcium carbonate.

Osteoporosis and Fracture Prevention

Calcium lactate gluconate, when administered to 19 non-menopausal women with osteoporosis during or after hormone therapy, significantly reduced bone fracture rate (Almustafa et al., 1992). In a separate study of 50 Chinese women aged 62–92 years, calcium lactate gluconate increased BMD of the hip more than exercise (Lau et al., 1992).

Human Absorption Study — Liposomal Calcium

A randomized crossover human absorption study evaluated the effects of solid-state liposomal calcium on blood calcium response and absorption efficiency compared with non-liposomal calcium. Subjects received a single dose of either solid-state liposomal calcium or non-liposomal calcium, and blood calcium levels were measured over an 8-hour period. Solid-state liposomal calcium significantly increased blood calcium levels at early time points (1–2 h; p < 0.05) and maintained elevated levels up to 8 hours post-administration. The AUC was higher in the liposomal group (2.94 mg·h/dL) compared to the non-liposomal group (1.88 mg·h/dL), representing a 1.56-fold increase in systemic calcium exposure.

Food Fortification and Beverage Applications

Calcium lactate gluconate is widely used in food and beverage applications due to its high water solubility, neutral taste, and excellent bioavailability. An in vivo bioavailability study has shown that calcium lactate gluconate has the highest bioavailability among calcium salts tested. It is particularly suitable for fortifying beverages, dairy products, and functional foods.

Safety and Regulatory

Calcium lactate gluconate is generally well tolerated. The most common side effects are gastrointestinal, including constipation and bloating, though these are less frequent with calcium lactate gluconate than with calcium carbonate due to its superior solubility. The Tolerable Upper Intake Level (UL) for elemental calcium is 2,500 mg/day for adults aged 19–50 years and 2,000 mg/day for adults aged 51 years and older.

Calcium lactate gluconate has GRAS (Generally Recognized As Safe) status under FDA with a low order of toxicity. The TGA has established a draft compositional guideline specifying heavy metal limits including arsenic <3.0 ppm and heavy metals <20 ppm, chloride <700 ppm, and sulphate <500 ppm. It is widely commercialized as a dietary supplement ingredient, pharmaceutical agent, and food additive. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

69$/KG

ONLINE MESSAGE

Please fill in a valid email address
Captcha Can not be empty

RELATED PRODUCTS

This website uses cookies to ensure you get the best experience on our website.

Accept Reject